207 related articles for article (PubMed ID: 21811868)
1. Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.
Acosta J; Catalan M; del Palacio-Pérez-Medel A; Montejo JC; De-La-Cruz-Bértolo J; Moragues MD; Pontón J; Finkelman MA; del Palacio A
Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):721-31. PubMed ID: 21811868
[TBL] [Abstract][Full Text] [Related]
2. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of invasive fungal disease using serum (1→3)-β-D-glucan: a bivariate meta-analysis.
Lu Y; Chen YQ; Guo YL; Qin SM; Wu C; Wang K
Intern Med; 2011; 50(22):2783-91. PubMed ID: 22082890
[TBL] [Abstract][Full Text] [Related]
4. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
Koo S; Bryar JM; Page JH; Baden LR; Marty FM
Clin Infect Dis; 2009 Dec; 49(11):1650-9. PubMed ID: 19863452
[TBL] [Abstract][Full Text] [Related]
8. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
Pazos C; Pontón J; Del Palacio A
J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
[TBL] [Abstract][Full Text] [Related]
9. Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
Bellanger AP; Grenouillet F; Henon T; Skana F; Legrand F; Deconinck E; Millon L
APMIS; 2011 Apr; 119(4-5):280-6. PubMed ID: 21492228
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of invasive fungal disease in hospitalized patients with chronic obstructive pulmonary disease.
Mohedano Del Pozo RB; Rubio Alonso M; Cuétara García MS
Rev Iberoam Micol; 2018; 35(3):117-122. PubMed ID: 30078525
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
[TBL] [Abstract][Full Text] [Related]
12. Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants.
Zhao D; Qiu G; Luo Z; Zhang Y
PLoS One; 2015; 10(4):e0123907. PubMed ID: 25874376
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
White PL; Price JS; Posso RB; Barnes RA
Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of the serum galactomannan and (1, 3)-β-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Cai X; Ni W; Wei C; Cui J
Intern Med; 2014; 53(21):2433-7. PubMed ID: 25366000
[TBL] [Abstract][Full Text] [Related]
15. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.
Hachem RY; Kontoyiannis DP; Chemaly RF; Jiang Y; Reitzel R; Raad I
J Clin Microbiol; 2009 Jan; 47(1):129-33. PubMed ID: 19005145
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Values and Limitations of (1,3)-β-D-Glucans and Galactomannan Assays for Invasive Fungal Infection in Patients Admitted to Pediatric Intensive Care Unit.
Zheng F; Zha H; Yang D; Deng J; Zhang Z
Mycopathologia; 2017 Apr; 182(3-4):331-338. PubMed ID: 27664106
[TBL] [Abstract][Full Text] [Related]
17. [Multiple serum antigenic assays for diagnosis of invasive fungal infections in non-neutropenic adult patients].
Jin J; Sun TY; Hu YJ; Li YM
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):660-4. PubMed ID: 21092632
[TBL] [Abstract][Full Text] [Related]
18. Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis.
Marty FM; Koo S
Med Mycol; 2009; 47 Suppl 1():S233-40. PubMed ID: 18720216
[TBL] [Abstract][Full Text] [Related]
19. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.
Ceesay MM; Desai SR; Berry L; Cleverley J; Kibbler CC; Pomplun S; Nicholson AG; Douiri A; Wade J; Smith M; Mufti GJ; Pagliuca A
Br J Haematol; 2015 Jan; 168(2):219-29. PubMed ID: 25179933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
